+22.4%
MRNA vs SN
+447.8%
-425.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.1% | +6.5% | +5.6% |
| 7D | -1.1% | -7.3% | +6.2% | +0.3% |
| 30D | +126.1% | -13.6% | +139.7% | +131.3% |
| 3M | +190.0% | +18.6% | +171.4% | +175.7% |
| 6M | +157.2% | +46.0% | +111.3% | +132.6% |
| YTD | +388.2% | +43.7% | +344.5% | +341.2% |
| 1Y | +467.0% | +39.2% | +427.9% | +414.6% |
| 3Y | +36.1% | +306.5% | -270.4% | +10.7% |
| All | +22.4% | +447.8% | -425.5% | -0.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling